Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine

The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented event, and in order to control its spread and minimize its damages, all efforts are immediately mobilized. Mass vaccination is considered a promising solution to combat this universal issue. However, given the urgent need for vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahrigharahkoshan, Shaghayegh, Gagnon, Louis-Philippe, Mathieu, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609955/
https://www.ncbi.nlm.nih.gov/pubmed/34853744
http://dx.doi.org/10.7759/cureus.19005
_version_ 1784603015396720640
author Shahrigharahkoshan, Shaghayegh
Gagnon, Louis-Philippe
Mathieu, Steve
author_facet Shahrigharahkoshan, Shaghayegh
Gagnon, Louis-Philippe
Mathieu, Steve
author_sort Shahrigharahkoshan, Shaghayegh
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented event, and in order to control its spread and minimize its damages, all efforts are immediately mobilized. Mass vaccination is considered a promising solution to combat this universal issue. However, given the urgent need for vaccine production, some of the side effects may not have been presented during trials and will only appear during the mass vaccination. Limited vasculitis cases have been reported so far following vaccination against COVID-19. We present a case of cutaneous leukocytoclastic vasculitis (LCV) induced following the first dose of the ChAdOx1 nCoV-19 vaccine in an otherwise healthy individual.
format Online
Article
Text
id pubmed-8609955
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-86099552021-11-30 Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine Shahrigharahkoshan, Shaghayegh Gagnon, Louis-Philippe Mathieu, Steve Cureus Dermatology The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented event, and in order to control its spread and minimize its damages, all efforts are immediately mobilized. Mass vaccination is considered a promising solution to combat this universal issue. However, given the urgent need for vaccine production, some of the side effects may not have been presented during trials and will only appear during the mass vaccination. Limited vasculitis cases have been reported so far following vaccination against COVID-19. We present a case of cutaneous leukocytoclastic vasculitis (LCV) induced following the first dose of the ChAdOx1 nCoV-19 vaccine in an otherwise healthy individual. Cureus 2021-10-24 /pmc/articles/PMC8609955/ /pubmed/34853744 http://dx.doi.org/10.7759/cureus.19005 Text en Copyright © 2021, Shahrigharahkoshan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Shahrigharahkoshan, Shaghayegh
Gagnon, Louis-Philippe
Mathieu, Steve
Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
title Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
title_full Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
title_fullStr Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
title_full_unstemmed Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
title_short Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
title_sort cutaneous leukocytoclastic vasculitis induction following chadox1 ncov-19 vaccine
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609955/
https://www.ncbi.nlm.nih.gov/pubmed/34853744
http://dx.doi.org/10.7759/cureus.19005
work_keys_str_mv AT shahrigharahkoshanshaghayegh cutaneousleukocytoclasticvasculitisinductionfollowingchadox1ncov19vaccine
AT gagnonlouisphilippe cutaneousleukocytoclasticvasculitisinductionfollowingchadox1ncov19vaccine
AT mathieusteve cutaneousleukocytoclasticvasculitisinductionfollowingchadox1ncov19vaccine

Ejemplares similares